Skip to main content
Erschienen in: Obesity Surgery 3/2016

01.03.2016 | Original Contributions

Risk of Biliary Events After Selective Cholecystectomy During Biliopancreatic Diversion with Duodenal Switch

verfasst von: Iswanto Sucandy, Moaz Abulfaraj, Mary Naglak, Gintaras Antanavicius

Erschienen in: Obesity Surgery | Ausgabe 3/2016

Einloggen, um Zugang zu erhalten

Abstract

Background

Approximately 20 % of adults over 40 years of age in the USA develop cholelithiasis (Topart et al. Surg Obes Relat Dis. 9(4):526–30, 2013). Despite a higher incidence of biliary complications reported in postbariatric patients, it remains controversial whether simultaneous routine cholecystectomy should be performed during biliopancreatic diversion and duodenal switch (BPD/DS) or if a selective approach is more appropriate. The aim of this study was to evaluate incidence of biliary complications in patients who underwent BPD/DS without simultaneous cholecystectomy.

Methods

Retrospective review of all patients who underwent BPD/DS between 2006 and 2012 was performed.

Results

A total of 361 consecutive patients were included in the study with mean age of 44.8 years (range 20–72), mean body weight of 317.2 lbs (range 205–547), and average body mass index (BMI) of 50.5 kg/m2 (range 34–71.4). Ninety-seven patients were males (26.8 %). Out of 239 patients who still had their gallbladder after the BPD/DS, 52 patients (22.7 %) developed subsequent biliary symptoms (13 patients (5.4 %) in the first year, 25 (11 %) in the second year, and 14 (6.1 %) beyond the second year). During the study period, 40 patients eventually underwent elective laparoscopic cholecystectomy, and 11 had urgent cholecystectomy (9 laparoscopic and 2 open). One patient underwent open common bile duct exploration for ascending cholangitis. Average follow-up was 31 months (12–72 months) with follow-up rate of 95.6 % at 12 months and 92.8 % at 18 months.

Conclusions

Leaving normal gallbladder in situ after BPD/DS is associated with an acceptable risk of biliary events. Risk of developing common bile duct stones is low; however, it may create treatment challenges.
Literatur
1.
Zurück zum Zitat Topart P, Becouarn G, Ritz P. Weight loss is more sustained after biliopancreatic diversion with duodenal switch than Roux-en-Y gastric bypass in superobese patients. Surg Obes Relat Dis. 2013;9(4):526–30.CrossRefPubMed Topart P, Becouarn G, Ritz P. Weight loss is more sustained after biliopancreatic diversion with duodenal switch than Roux-en-Y gastric bypass in superobese patients. Surg Obes Relat Dis. 2013;9(4):526–30.CrossRefPubMed
2.
Zurück zum Zitat Mason EE, Renquist KE. Gallbladder management in obesity surgery. Obes Surg. 2002;12(2):222–9.CrossRefPubMed Mason EE, Renquist KE. Gallbladder management in obesity surgery. Obes Surg. 2002;12(2):222–9.CrossRefPubMed
3.
Zurück zum Zitat Kim JJ, Schirmer B. Safety and efficacy of simultaneous cholecystectomy at Roux-en-Y gastric bypass. Surg Obes Relat Dis. 2009;5(1):48–53.CrossRefPubMed Kim JJ, Schirmer B. Safety and efficacy of simultaneous cholecystectomy at Roux-en-Y gastric bypass. Surg Obes Relat Dis. 2009;5(1):48–53.CrossRefPubMed
4.
Zurück zum Zitat Hamad GG, Ikramuddin S, Gourash WF, et al. Elective cholecystectomy during laparoscopic Roux-en-Y gastric bypass: is it worth the wait? Obes Surg. 2003;13(1):76–81.CrossRefPubMed Hamad GG, Ikramuddin S, Gourash WF, et al. Elective cholecystectomy during laparoscopic Roux-en-Y gastric bypass: is it worth the wait? Obes Surg. 2003;13(1):76–81.CrossRefPubMed
5.
Zurück zum Zitat Sugerman HJ, Brewer WH, Shiffman M, et al. A multicenter, placebo-controlled, randomized, double-blind, prospective trial of prophylactic ursodeoxycholic acid for the prevention of gallstone formation following gastric-bypass-induced rapid weight loss. Am J Surg. 1995;169(1):91–6. discussion 96–7.CrossRefPubMed Sugerman HJ, Brewer WH, Shiffman M, et al. A multicenter, placebo-controlled, randomized, double-blind, prospective trial of prophylactic ursodeoxycholic acid for the prevention of gallstone formation following gastric-bypass-induced rapid weight loss. Am J Surg. 1995;169(1):91–6. discussion 96–7.CrossRefPubMed
6.
Zurück zum Zitat Worobetz LJ, Inglis FG, Shaffer EA. The effect of ursodeoxycholic acid therapy on gallstone formation in the morbidly obese during rapid weight loss. Am J Gastroenterol. 1993;88(10):1705–10.PubMed Worobetz LJ, Inglis FG, Shaffer EA. The effect of ursodeoxycholic acid therapy on gallstone formation in the morbidly obese during rapid weight loss. Am J Gastroenterol. 1993;88(10):1705–10.PubMed
7.
Zurück zum Zitat Bastouly M, Arasaki CH, Ferreira JB, et al. Early changes in postprandial gallbladder emptying in morbidly obese patients undergoing Roux-en-Y gastric bypass: correlation with the occurrence of biliary sludge and gallstones. Obes Surg. 2009;19(1):22–8.CrossRefPubMed Bastouly M, Arasaki CH, Ferreira JB, et al. Early changes in postprandial gallbladder emptying in morbidly obese patients undergoing Roux-en-Y gastric bypass: correlation with the occurrence of biliary sludge and gallstones. Obes Surg. 2009;19(1):22–8.CrossRefPubMed
8.
Zurück zum Zitat Nagem RG, Lázaro-da-Silva A, de Oliveira RM, et al. Gallstone-related complications after Roux-en-Y gastric bypass: a prospective study. Hepatobiliary Pancreat Dis Int. 2012;11(6):630–5.CrossRefPubMed Nagem RG, Lázaro-da-Silva A, de Oliveira RM, et al. Gallstone-related complications after Roux-en-Y gastric bypass: a prospective study. Hepatobiliary Pancreat Dis Int. 2012;11(6):630–5.CrossRefPubMed
9.
Zurück zum Zitat Scopinaro N, Gianetta E, Civalleri D, et al. Bilio-pancreatic bypass for obesity: II. Initial experience in man. Br J Surg. 1979;66(9):618–20.CrossRefPubMed Scopinaro N, Gianetta E, Civalleri D, et al. Bilio-pancreatic bypass for obesity: II. Initial experience in man. Br J Surg. 1979;66(9):618–20.CrossRefPubMed
10.
Zurück zum Zitat Scopinaro N, Gianetta E, Civalleri D, et al. Two years of clinical experience with biliopancreatic bypass for obesity. Am J Clin Nutr. 1980;33(2 Suppl):506–14.PubMed Scopinaro N, Gianetta E, Civalleri D, et al. Two years of clinical experience with biliopancreatic bypass for obesity. Am J Clin Nutr. 1980;33(2 Suppl):506–14.PubMed
11.
Zurück zum Zitat Marceau P, Biron S, Bourque RA, et al. Biliopancreatic diversion with a new type of gastrectomy. Obes Surg. 1993;3(1):29–35.CrossRefPubMed Marceau P, Biron S, Bourque RA, et al. Biliopancreatic diversion with a new type of gastrectomy. Obes Surg. 1993;3(1):29–35.CrossRefPubMed
12.
Zurück zum Zitat Iglézias Brandão de Oliveira C, Adami Chaim E, da Silva BB. Impact of rapid weight reduction on risk of cholelithiasis after bariatric surgery. Obes Surg. 2003;13(4):625–8.CrossRefPubMed Iglézias Brandão de Oliveira C, Adami Chaim E, da Silva BB. Impact of rapid weight reduction on risk of cholelithiasis after bariatric surgery. Obes Surg. 2003;13(4):625–8.CrossRefPubMed
13.
Zurück zum Zitat Papasavas PK, Gagné DJ, Ceppa FA, et al. Routine gallbladder screening not necessary in patients undergoing laparoscopic Roux-en-Y gastric bypass. Surg Obes Relat Dis. 2006;2(1):41–6.CrossRefPubMed Papasavas PK, Gagné DJ, Ceppa FA, et al. Routine gallbladder screening not necessary in patients undergoing laparoscopic Roux-en-Y gastric bypass. Surg Obes Relat Dis. 2006;2(1):41–6.CrossRefPubMed
14.
Zurück zum Zitat Patel KR, White SC, Tejirian T, et al. Gallbladder management during laparoscopic Roux-en-Y gastric bypass surgery: routine preoperative screening for gallstones and postoperative prophylactic medical treatment are not necessary. Am Surg. 2006;72(10):857–61.PubMed Patel KR, White SC, Tejirian T, et al. Gallbladder management during laparoscopic Roux-en-Y gastric bypass surgery: routine preoperative screening for gallstones and postoperative prophylactic medical treatment are not necessary. Am Surg. 2006;72(10):857–61.PubMed
15.
Zurück zum Zitat Ammori BJ, Vezakis A, Davides D, et al. Laparoscopic cholecystectomy in morbidly obese patients. Surg Endosc. 2001;15(11):1336–9.CrossRefPubMed Ammori BJ, Vezakis A, Davides D, et al. Laparoscopic cholecystectomy in morbidly obese patients. Surg Endosc. 2001;15(11):1336–9.CrossRefPubMed
16.
Zurück zum Zitat Mutignani M, Marchese M, Tringali A, et al. Laparoscopy-assisted ERCP after biliopancreatic diversion. Obes Surg. 2007;17(2):251–4.CrossRefPubMed Mutignani M, Marchese M, Tringali A, et al. Laparoscopy-assisted ERCP after biliopancreatic diversion. Obes Surg. 2007;17(2):251–4.CrossRefPubMed
17.
Zurück zum Zitat Bardaro SJ, Gagner M, Consten E. Routine cholecystectomy during laparoscopic biliopancreatic diversion with duodenal switch is not necessary. Surg Obes Relat Dis. 2007;3(5):549–53.CrossRefPubMed Bardaro SJ, Gagner M, Consten E. Routine cholecystectomy during laparoscopic biliopancreatic diversion with duodenal switch is not necessary. Surg Obes Relat Dis. 2007;3(5):549–53.CrossRefPubMed
18.
Zurück zum Zitat Sakorafas GH, Milingos D, Peros G. Asymptomatic cholelithiasis: is cholecystectomy really needed? A critical reappraisal 15 years after the introduction of laparoscopic cholecystectomy. Dig Dis Sci. 2007;52(5):1313–25.CrossRefPubMed Sakorafas GH, Milingos D, Peros G. Asymptomatic cholelithiasis: is cholecystectomy really needed? A critical reappraisal 15 years after the introduction of laparoscopic cholecystectomy. Dig Dis Sci. 2007;52(5):1313–25.CrossRefPubMed
19.
Zurück zum Zitat Schirmer BD, Winters KL, Edlich RF. Cholelithiasis and cholecystitis. J Long Term Eff Med Implants. 2005;15(3):329–38.CrossRefPubMed Schirmer BD, Winters KL, Edlich RF. Cholelithiasis and cholecystitis. J Long Term Eff Med Implants. 2005;15(3):329–38.CrossRefPubMed
20.
Zurück zum Zitat Tsirline VB, Keilani ZM, El Djouzi S, et al. How frequently and when do patients undergo cholecytectomy after bariatric surgery? Surg Obes Relat Dis. 2014;10(2):313–21.CrossRefPubMed Tsirline VB, Keilani ZM, El Djouzi S, et al. How frequently and when do patients undergo cholecytectomy after bariatric surgery? Surg Obes Relat Dis. 2014;10(2):313–21.CrossRefPubMed
21.
Zurück zum Zitat Worni M, Guller U, Shah A, et al. Cholecystectomy concomitant with laparoscopic gastric bypass: a trend analysis of the nationwide inpatient sample from 2001–2008. Obes Surg. 2012;22(2):220–9.CrossRefPubMed Worni M, Guller U, Shah A, et al. Cholecystectomy concomitant with laparoscopic gastric bypass: a trend analysis of the nationwide inpatient sample from 2001–2008. Obes Surg. 2012;22(2):220–9.CrossRefPubMed
22.
Zurück zum Zitat Escalona A, Boza C, Munoz R, et al. Routine preoperative ultrasonography and selective cholecystectomy in laparoscopic Roux en Y gastric bypass. Why not? Obes Surg. 2008;18(1):47–51.CrossRefPubMed Escalona A, Boza C, Munoz R, et al. Routine preoperative ultrasonography and selective cholecystectomy in laparoscopic Roux en Y gastric bypass. Why not? Obes Surg. 2008;18(1):47–51.CrossRefPubMed
23.
Zurück zum Zitat Fobi M, Lee H, Igwe D, et al. Prophylactic cholecytectomy with gastric bypass operation: incidence of gallbladder disease. Obes Surg. 2002;12(3):350–3.CrossRefPubMed Fobi M, Lee H, Igwe D, et al. Prophylactic cholecytectomy with gastric bypass operation: incidence of gallbladder disease. Obes Surg. 2002;12(3):350–3.CrossRefPubMed
24.
Zurück zum Zitat Csendes A, Burdiles P, Smok G, et al. Histologic findings of gallbladder mucosa in 87 patients with morbid obesity without gallstones compared with 87 control subjects. J Gastrointest Surg. 2003;7(4):547–51.CrossRefPubMed Csendes A, Burdiles P, Smok G, et al. Histologic findings of gallbladder mucosa in 87 patients with morbid obesity without gallstones compared with 87 control subjects. J Gastrointest Surg. 2003;7(4):547–51.CrossRefPubMed
25.
Zurück zum Zitat Guadalajara H, Sanz Baro R, Pascual I, et al. Is prophylactic cholecystectomy useful in obese patients undergoing gastric bypass? Obes Surg. 2006;16(7):883–5.CrossRefPubMed Guadalajara H, Sanz Baro R, Pascual I, et al. Is prophylactic cholecystectomy useful in obese patients undergoing gastric bypass? Obes Surg. 2006;16(7):883–5.CrossRefPubMed
26.
Zurück zum Zitat Portenier DD, Grant JP, Blackwood HS, et al. Expectant management of the asymptomatic gallbladder at Roux-en-Y gastric bypass. Surg Obes Relat Dis. 2007;3(4):476–9.CrossRefPubMed Portenier DD, Grant JP, Blackwood HS, et al. Expectant management of the asymptomatic gallbladder at Roux-en-Y gastric bypass. Surg Obes Relat Dis. 2007;3(4):476–9.CrossRefPubMed
Metadaten
Titel
Risk of Biliary Events After Selective Cholecystectomy During Biliopancreatic Diversion with Duodenal Switch
verfasst von
Iswanto Sucandy
Moaz Abulfaraj
Mary Naglak
Gintaras Antanavicius
Publikationsdatum
01.03.2016
Verlag
Springer US
Erschienen in
Obesity Surgery / Ausgabe 3/2016
Print ISSN: 0960-8923
Elektronische ISSN: 1708-0428
DOI
https://doi.org/10.1007/s11695-015-1786-4

Weitere Artikel der Ausgabe 3/2016

Obesity Surgery 3/2016 Zur Ausgabe

Update Chirurgie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.

S3-Leitlinie „Diagnostik und Therapie des Karpaltunnelsyndroms“

Karpaltunnelsyndrom BDC Leitlinien Webinare
CME: 2 Punkte

Das Karpaltunnelsyndrom ist die häufigste Kompressionsneuropathie peripherer Nerven. Obwohl die Anamnese mit dem nächtlichen Einschlafen der Hand (Brachialgia parästhetica nocturna) sehr typisch ist, ist eine klinisch-neurologische Untersuchung und Elektroneurografie in manchen Fällen auch eine Neurosonografie erforderlich. Im Anfangsstadium sind konservative Maßnahmen (Handgelenksschiene, Ergotherapie) empfehlenswert. Bei nicht Ansprechen der konservativen Therapie oder Auftreten von neurologischen Ausfällen ist eine Dekompression des N. medianus am Karpaltunnel indiziert.

Prof. Dr. med. Gregor Antoniadis
Berufsverband der Deutschen Chirurgie e.V.

S2e-Leitlinie „Distale Radiusfraktur“

Radiusfraktur BDC Leitlinien Webinare
CME: 2 Punkte

Das Webinar beschäftigt sich mit Fragen und Antworten zu Diagnostik und Klassifikation sowie Möglichkeiten des Ausschlusses von Zusatzverletzungen. Die Referenten erläutern, welche Frakturen konservativ behandelt werden können und wie. Das Webinar beantwortet die Frage nach aktuellen operativen Therapiekonzepten: Welcher Zugang, welches Osteosynthesematerial? Auf was muss bei der Nachbehandlung der distalen Radiusfraktur geachtet werden?

PD Dr. med. Oliver Pieske
Dr. med. Benjamin Meyknecht
Berufsverband der Deutschen Chirurgie e.V.

S1-Leitlinie „Empfehlungen zur Therapie der akuten Appendizitis bei Erwachsenen“

Appendizitis BDC Leitlinien Webinare
CME: 2 Punkte

Inhalte des Webinars zur S1-Leitlinie „Empfehlungen zur Therapie der akuten Appendizitis bei Erwachsenen“ sind die Darstellung des Projektes und des Erstellungswegs zur S1-Leitlinie, die Erläuterung der klinischen Relevanz der Klassifikation EAES 2015, die wissenschaftliche Begründung der wichtigsten Empfehlungen und die Darstellung stadiengerechter Therapieoptionen.

Dr. med. Mihailo Andric
Berufsverband der Deutschen Chirurgie e.V.